Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Perimeter Medical Imaging AI ( (TSE:PINK) ).
Perimeter Medical Imaging AI has received U.S. FDA premarket approval for Claire, the first AI-enabled imaging device cleared in the United States for intraoperative breast cancer margin assessment. Combining proprietary AI with wide-field OCT, Claire provides high-resolution, real-time visualization of excised tissue margins to help surgeons identify residual cancer during breast-conserving surgery and potentially reduce the need for re-operations.
The pivotal clinical trial supporting approval showed that Claire achieved 88.1% margin accuracy and produced a statistically significant reduction in patients with residual cancer compared with the standard of care alone. Backed by prior Breakthrough Device designation and a US$7.4 million CPRIT grant, Perimeter plans a nationwide launch in the coming weeks, positioning Claire as a potential new standard of care in breast surgery and strengthening the company’s competitive edge through its expanding proprietary image library and continuously improving AI engine.
The most recent analyst rating on (TSE:PINK) stock is a Hold with a C$0.24 price target. To see the full list of analyst forecasts on Perimeter Medical Imaging AI stock, see the TSE:PINK Stock Forecast page.
Spark’s Take on TSE:PINK Stock
According to Spark, TipRanks’ AI Analyst, TSE:PINK is a Neutral.
The score is held down primarily by weak financial quality (persistent losses and negative operating/free cash flow) despite solid gross margins and revenue growth, and by bearish technicals with the stock trading below key moving averages. Valuation adds limited support because the negative P/E reflects ongoing losses and no dividend yield is available.
To see Spark’s full report on TSE:PINK stock, click here.
More about Perimeter Medical Imaging AI
Perimeter Medical Imaging AI, Inc. is a commercial-stage medical technology company focused on applying artificial intelligence to optical coherence tomography (OCT) imaging for cancer surgery. The company develops real-time, high-resolution imaging tools to assist surgeons with intraoperative margin assessment, with an initial market focus on breast-conserving surgery in the U.S.
Average Trading Volume: 114,178
Technical Sentiment Signal: Sell
Current Market Cap: C$46.66M
For a thorough assessment of PINK stock, go to TipRanks’ Stock Analysis page.